Quality specifications for peptide drugs: a regulatory‐pharmaceutical approach
- 11 September 2009
- journal article
- review article
- Published by Wiley in Journal of Peptide Science
- Vol. 15 (11), 697-710
- https://doi.org/10.1002/psc.1167
Abstract
Peptide drugs, as all types of pharmaceuticals, require adequate specifications (i.e. quality attributes, procedures and acceptance criteria) as part of their quality assurance to ensure the safety and efficacy of drug substances (i.e. active pharmaceutical ingredients) and drug products (i.e. finished pharmaceutical dosage forms). Compendial monographs are updated regularly to keep up with the most recent advances in peptide synthesis (e.g. reduced by‐products) and analytical technology. Nevertheless, currently applied pharmacopoeial peptide specifications are barely harmonized yet (e.g. large differences between the European Pharmacopoeia and the United States Pharmacopeia), increasing the manufacturers' burden of performing analytical procedures in different ways, using different acceptance criteria. Additionally, the peptide monographs are not always consistent within a single pharmacopoeia. In this review, we highlight the main differences and similarities in compendial peptide specifications (including identification, purity and assay). Based on comparison, and together with additional information from peptide drug substance manufacturers and public evaluation reports on registration files of non‐pharmacopoeial peptide drugs, a consistent monograph structure is proposed. Copyright © 2009 European Peptide Society and John Wiley & Sons, Ltd.This publication has 53 references indexed in Scilit:
- Novel endogenous peptide agonists of cannabinoid receptorsThe FASEB Journal, 2009
- Is HPLC assay for drug substance a useful quality control attribute?Journal of Pharmaceutical and Biomedical Analysis, 2007
- Studies on deprotection of cysteine and selenocysteine side-chain protecting groupsJournal of Peptide Science, 2006
- Amyloid Fibrils of Glucagon Characterized by High-Resolution Atomic Force MicroscopyBiophysical Journal, 2006
- Protein aggregation and bioprocessingThe AAPS Journal, 2006
- Quantitative NMR spectroscopy—Applications in drug analysisJournal of Pharmaceutical and Biomedical Analysis, 2005
- How to measure and predict the molar absorption coefficient of a proteinProtein Science, 1995
- A novel mechanism for oxidative cleavage of prolyl peptides induced by the hydroxyl radicalBiochemical and Biophysical Research Communications, 1990
- Studies on racemization associated with the use of benzotriazol‐1‐yl‐tris (dimethylamino)phosphonium hexafluorophosphate (BOP)International Journal of Peptide and Protein Research, 1989
- Reaction of Anhydrous Formic Acid with Proteins1Journal of the American Chemical Society, 1959